Atlas Trials

Safety and Immunogenicity of 2-dose Inactivated COVID-19 Vaccine in Kidney Transplant Recipients

Clinical trial NCT04969614 · UNKNOWN

Trial details

NCT number
NCT04969614
Sponsor
West China Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Kidney TransplantationSARS-CoV-2 Acute Respiratory DiseaseVaccine
Start date
2021-08-01
Primary completion
2021-11-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.